PluroGel

DRUG4 trials

Sponsors

PluroGen Therapeutics, Inc, Medline Industries, University of Manitoba

Conditions

Arterial UlcerBurnsDiabetic Foot UlcerInfectionVenous Ulcer

Phase 1

A Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries

RecruitingNCT04893863

University of ManitobaBurns

Start: 2021-10-01End: 2029-06-01Target: 20Updated: 2026-05-14

A Between Patient Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries

RecruitingNCT05000983

University of ManitobaBurns

Start: 2021-10-20End: 2029-12-31Target: 25Updated: 2026-05-14

Phase 2

Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers

CompletedNCT02091596

PluroGen Therapeutics, IncDiabetic Foot Ulcer, Infection

Start: 2013-10-31End: 2014-09-30Updated: 2014-09-25

Unknown Phase

PluroGel on Wounds of Mixed Etiology

TerminatedNCT03275831

Medline IndustriesArterial Ulcer, Venous Ulcer

Start: 2018-01-08End: 2021-10-05Updated: 2021-10-20